Cargando…
Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
Breast cancer is one of the most deadly forms of cancer in women worldwide. Better prediction of breast cancer prognosis is essential for more personalized treatment. In this study, we aimed to infer patient‐specific subpathway activities to reveal a functional signature associated with the prognosi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111825/ https://www.ncbi.nlm.nih.gov/pubmed/29971923 http://dx.doi.org/10.1111/jcmm.13720 |
_version_ | 1783350739964264448 |
---|---|
author | Han, Junwei Liu, Siyao Jiang, Ying Xu, Chaohan Zheng, Baotong Jiang, Minghao Yang, Haixiu Su, Fei Li, Chunquan Zhang, Yunpeng |
author_facet | Han, Junwei Liu, Siyao Jiang, Ying Xu, Chaohan Zheng, Baotong Jiang, Minghao Yang, Haixiu Su, Fei Li, Chunquan Zhang, Yunpeng |
author_sort | Han, Junwei |
collection | PubMed |
description | Breast cancer is one of the most deadly forms of cancer in women worldwide. Better prediction of breast cancer prognosis is essential for more personalized treatment. In this study, we aimed to infer patient‐specific subpathway activities to reveal a functional signature associated with the prognosis of patients with breast cancer. We integrated pathway structure with gene expression data to construct patient‐specific subpathway activity profiles using a greedy search algorithm. A four‐subpathway prognostic signature was developed in the training set using a random forest supervised classification algorithm and a prognostic score model with the activity profiles. According to the signature, patients were classified into high‐risk and low‐risk groups with significantly different overall survival in the training set (median survival of 65 vs 106 months, P = 1.82e‐13) and test set (median survival of 75 vs 101 months, P = 4.17e‐5). Our signature was then applied to five independent breast cancer data sets and showed similar prognostic values, confirming the accuracy and robustness of the subpathway signature. Stratified analysis suggested that the four‐subpathway signature had prognostic value within subtypes of breast cancer. Our results suggest that the four‐subpathway signature may be a useful biomarker for breast cancer prognosis. |
format | Online Article Text |
id | pubmed-6111825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61118252018-09-01 Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer Han, Junwei Liu, Siyao Jiang, Ying Xu, Chaohan Zheng, Baotong Jiang, Minghao Yang, Haixiu Su, Fei Li, Chunquan Zhang, Yunpeng J Cell Mol Med Original Articles Breast cancer is one of the most deadly forms of cancer in women worldwide. Better prediction of breast cancer prognosis is essential for more personalized treatment. In this study, we aimed to infer patient‐specific subpathway activities to reveal a functional signature associated with the prognosis of patients with breast cancer. We integrated pathway structure with gene expression data to construct patient‐specific subpathway activity profiles using a greedy search algorithm. A four‐subpathway prognostic signature was developed in the training set using a random forest supervised classification algorithm and a prognostic score model with the activity profiles. According to the signature, patients were classified into high‐risk and low‐risk groups with significantly different overall survival in the training set (median survival of 65 vs 106 months, P = 1.82e‐13) and test set (median survival of 75 vs 101 months, P = 4.17e‐5). Our signature was then applied to five independent breast cancer data sets and showed similar prognostic values, confirming the accuracy and robustness of the subpathway signature. Stratified analysis suggested that the four‐subpathway signature had prognostic value within subtypes of breast cancer. Our results suggest that the four‐subpathway signature may be a useful biomarker for breast cancer prognosis. John Wiley and Sons Inc. 2018-07-04 2018-09 /pmc/articles/PMC6111825/ /pubmed/29971923 http://dx.doi.org/10.1111/jcmm.13720 Text en © 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Han, Junwei Liu, Siyao Jiang, Ying Xu, Chaohan Zheng, Baotong Jiang, Minghao Yang, Haixiu Su, Fei Li, Chunquan Zhang, Yunpeng Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer |
title | Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer |
title_full | Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer |
title_fullStr | Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer |
title_full_unstemmed | Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer |
title_short | Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer |
title_sort | inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111825/ https://www.ncbi.nlm.nih.gov/pubmed/29971923 http://dx.doi.org/10.1111/jcmm.13720 |
work_keys_str_mv | AT hanjunwei inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer AT liusiyao inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer AT jiangying inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer AT xuchaohan inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer AT zhengbaotong inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer AT jiangminghao inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer AT yanghaixiu inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer AT sufei inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer AT lichunquan inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer AT zhangyunpeng inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer |